444 search results for “drug” in the Student website
-
Barbara ScalviniFaculty of Science
-
Menno HoekstraFaculty of Science
-
Joachim van GuyseFaculty of Science
-
Amy HarmsFaculty of Science
-
Martijn MansonFaculty of Science
-
Chunyuan YinFaculty of Science
-
Dimitra EleftheriouFaculty of Science
-
Eric BangFaculty of Science
-
Jill de MolFaculty of Science
-
Laura BosmansFaculty of Science
-
Ming SunFaculty of Science
-
Zhiyuan TanFaculty of Science
-
Mengxu ZhangFaculty of Science
-
Jannik RouselFaculty of Science
-
Xiao ChenFaculty of Science
-
Zixuan WangFaculty of Science
-
Yuchen GuoFaculty of Science
-
Jesika Habip GatenyoFaculty of Science
-
Yinru ChenFaculty of Science
-
Divakar BuddaFaculty of Science
-
Sebastian TandarFaculty of Science
-
Ilze BotFaculty of Science
-
Matthias BarzFaculty of Science
-
Micha DrukkerFaculty of Science
-
Gerhard BurgerFaculty of Science
-
Dongdong BiFaculty of Science
-
‘Pharmacogenetics will become part of patient care’
Does medicine make patients feel better or worse? We are getting better at predicting this from people’s DNA profiles, says Professor Jesse Swen. ‘It never fails to fascinate me how one DNA base pair can have such a huge effect on treatment with medication and the outcome.’
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
€10.6 million for innovative toolboxes to tackle brain cancer
Researchers at the Universities of Amsterdam (Uva) and Leiden together with the Netherlands Cancer Institute and Oncode Institute have received a €10,6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma. This is a deadly primary brain tumour for which no curing…
-
Powerful new Leiden 'super antibiotic' may overcome resistance
The prestigious journal Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. ‘The idea was to tweak the original antibiotic and create a next-generation drug’, says Nathaniel Martin, professor…
-
One million euros grant for smart antibiotic combinations – tackling resistant infections and antimicrobial resistance
Optimised antibiotic combinations can combat bacteria more effectively while also slowing the development of resistance. Scientists from five European countries are joining forces to identify such combinations and provide tools for others to do the same. The project is led by Professor Coen van Hasselt…
-
Obesity and medication: when does bodyweight matter?
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and PhD researcher Koen van Rhee studied how obesity affects blood levels of two commonly used medicines. He also developed a method for pharmaceutical companies to test new drugs on this patient group.
-
Extraterrestrial life, AI and more: these are the most-read Leiden Science articles of 2025
Speculation about alien life, a new nitrogen map, AI as a thesis supervisor, groundbreaking telescopes and multi-million-euro investments to combat antimicrobial resistance – the diversity of these topics shows that our readers are just as broadly interested as our researchers. Discover the most-read…
- News
-
More research on side effects: ‘Side effects are not a side issue’
We need to be quicker and better at discovering side effects. In her inaugural lecture, Agnes Kant, Professor by Special Appointment of Innovation of Pharmacovigilance, calls for more research on these adverse effects.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
Miranda van EckFaculty of Science
-
Professor and Knight: Joke Bouwstra Receives Royal Honor
A memorable farewell symposium and a royal distinction: Professor Joke Bouwstra could not have completed her career at Leiden with more pleasure. On Friday, 14 June, she received a Royal Honor from Leiden Mayor Peter van der Velden, who appointed Bouwstra as a Knight in the Order of the Dutch Lion for…
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Let the robot lend a hand in the pharmacy (it’s more sustainable too)
Can a robot help prepare cancer medication in a hospital pharmacy? That’s what hospital pharmacist Tjerk Geersing investigated in his PhD research. He compared manual and automated preparations in terms of quality, efficiency, and safety. He graduated on 19 March.
-
Unlocking the secrets of DNA repair: Sarah’s curiosity might lead to new cancer treatments
How do cells repair their damaged DNA—and what happens when that process is hindered and cancer arises? Sarah Moser has taken a closer look during her PhD, uncovering surprising insights that could help improve future cancer treatments.
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster and better, scientists across the country are joining forces. The Next Generation ImmunoDermatology (NGID) project, with LACDR professor Robert Rissmann…
-
Tahmina FariabyFaculty of Science
-
Jeroen MolenaarFaculty of Science
-
Sophieke LemsFaculty of Science
-
Roy SnijckersFaculty of Science
-
Gijs van der MarelFaculty of Science
-
Peter ten DijkeFaculteit Geneeskunde